Calcineurin nephrotoxicity

Advances in Chronic Kidney Disease

Volumn 13, Issue 1, 2006, Pages 47-55

  Williams, David ^a   Haragsim, Lukas ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Cyclosporine nephrotoxicity; Kidney transplantation; Tacrolimus nephrotoxicity; Transplant failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM; CALMODULIN; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RAPAMYCIN; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA;

ACNE; ALOPECIA; ANEMIA; ANGIONEUROTIC EDEMA; CADAVER KIDNEY; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; EDEMA; FOLLICULITIS; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCISIONAL HERNIA; KIDNEY GRAFT REJECTION; LEUKOPENIA; LONG TERM CARE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SKIN DISEASE; SKIN ULCER; SUPPURATIVE HIDRADENITIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT FAILURE; TREMOR; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

EID: 30444434587     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2005.11.001     Document Type: Article

References (51)

1. K. Solez, F. Vincenti, R. Filo Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine Transplantation 66 1998 1736 1740
2. H. Meier-Kriesche, J. Schold, B. Kaplan Long-term renal allograft survival Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4 2004 1289 1295
3. A. Melk, P. Halloran Immunosuppressive Agents Used in Transplantation R.J. Johnson Comprehensive Clinical Nephrology 2000 Mosby Philadelphia, PA 1057 1069
4. R.J. Johnson, C.E. Alpers, A. Yoshimura Renal Injury from angiotensin II mediated hypertension Hypertension 19 1992 464 474
5. M. Lassila Interaction of cyclosporine A and the renin-angiotensin system New perspectives Curr Drug Metab 3 2002 61 71
6. E.J. Barros, M.A. Boim, H. Ajzen Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity Kidney Int 32 1987 19 25
7. B.M. Murray, M.S. Paller, T.F. Ferris Effect of cyclosporine administration on renal hemodynamics in conscious rats Kidney Int 28 1985 767 774
8. R. Pichler, N. Franceschini, B. Young Pathogenesis of cyclosporine nephropathy Roles of angiotensin II and osteopontin J Am Soc Nephrol 6 1995 1186 1196
9. E. Von Willebrand, P. Hayry, J. Ahonen Differential diagnosis of cyclosporine nephrotoxicity versus rejection by fine needle aspiration biopsy Kidney Int 24 1983 418
10. E. Von Willebrand, P. Hayry Cyclosporine A deposits in renal allografts Lancet 2 1983 189 192
11. N. Perico, G. Remuzzi Cyclosporine-induced renal dysfunction in experimental animals and humans Transplant Rev 5 1991 63 80
12. J.D. Conger, G.E. Kim, J.B. Robinette Effects of Ang II, ETA, and Txa2 receptor antagonists on cyclosporine A renal vasoconstriction Am J Physiol 267 1994 F443 F449
13. A. Benigni, N. Perico, J.R. Ladny Increased urinary excretion of endothelin-1 and its precursor big endothelin-1 in rats chronically treated with cyclosporine Transplantation 52 1991 175 177
14. J. Xin, T. Homma, T. Matsusaka Suppression of cyclosporine A nephrotoxicity in vivo by transforming growth factor B receptor immunoglobulin G chimeric protein Transplantation 77 2004 1433 1442
15. F.S. Shihab, W.M. Bennett, T.F. Andoh Effect of nitric oxide modulation on TGF- Beta1 and matrix proteins in chronic cyclosporine neprotoxicity Kidney Int 58 2000 1174 1185
16. L. Racusen, K. Solez, R. Colvin The Banff 97 working classification of renal allograft pathology Kidney Int 5 1999 713 723
17. M.J. Mihatsch, B. Ryffel, F. Gudat The differential diagnosis between rejection and cyclosporine toxicity Kidney Int 48 suppl 52 1995 S63 S69
18. M.J. Mihatsch, G. Thiel, B. Ryffel Histopathology of cyclosporine nephrotoxicity Transplantation Proc 20 suppl 3 1988 759 771
19. B.M. Murray, M.S. Paller Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats Clin Nephrol 25 suppl 1986 S37 S39
20. M.C. Churchill, P.C. Churchill, A.K. Bidani The effects of cyclosporine in Lewis rats with native and transplanted kidneys Transplantation 55 1993 1256 1260
21. D.H. Peters, A. Fitton, G.L. Plosker Tacrolimus A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation Drugs 46 1993 764 794
22. K. Solez, L.C. Racusen, M. Mihatsch Nephrotoxicity of cyclosporine and newer immunosuppressive agents K. Solez L.C. Racusen M. Billingham Solid Organ Allograft Rejection 1996 Marcel Dekker New York, NY 587 620
23. M.E. Falkenheim, F.G. Cosio, D.D. Sedmak Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine Transplantation 62 1996 364 370
24. B.D. Myers, R. Sibley, L. Newton The long-term course of cyclosporine associated chronic nephropathy Kidney Int 33 1988 590 600
25. J.S. Zaltman, Y. Pei Cyclosporine nephrotoxicity in lung transplant recipients Transplantation 54 1992 875 878
26. B. Nankivell, R.J. Borrows, C. Fung The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326 2333
27. J.G. O'Grady, A. Forbes, K. Rolles An analysis of cyclosporine efficacy and toxicity after liver transplantation Transplantation 45 1988 575 579
28. G. Mourad, C. Vela, J. Ribstein Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy Transplantation 65 1998 661 667
29. R.W. Gruessner, G.W. Burke, R. Stratta A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation Transplantation 61 1996 261 273
30. A. Dieterle, A. Gratwohl, H. Nizze Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients Transplantation 49 1990 1093 1110
31. G. Feutren, M.J. Mihatsch International kidney biopsy registry of cyclosporine in autoimmune diseases. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases N Engl J Med 326 1992 1654 1660
32. N. Krieger, B. Becker, D. Heisey Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts Transplantation 75 2003 1677 1682
33. J.M. Cecka Then UNOS Scientific Renal Transplant Registry J.M. Cecka P.I. Terasaki Clinical Transplants 2000 2001 UCLA Immunogenetics Center Los Angeles, CA
34. A. Melk, P. Halloran Immunosuppressive agents used in transplantation R.J. Johnson Comprehensive Clinical Nephrology 2000 Mosby Philadelphia, PA 1057 1069
35. A. Melk, P. Halloran Immunosuppressive Agents Used in Transplantation R.J. Johnson Comprehensive Clinical Nephrology 2000 Mosby Philadelphia, PA 1057 1069
36. E. Mahe, E. Morelon, S. Lechaton Cutaneous adverse events in renal transplant recipients receiving sirolimus based therapy Transplantation 79 2005 476 482
37. P. Dean, W. Lend, M. Prieto Wound healing complications after kidney transplantation Transplantation 77 2004 1555 1561
38. J. Morrisett, G. Abdel-Fattah, B. Kahan Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant patients Transplant Proc 35 2003 143S 150S
39. E. Dittrich, S. Schmeldeinst, A. Soleiman Rapamycin associated post-transplantation glomerulonephritis and its remisssion after reintroduction of calcineurin-inhibition therapy Transplant Int 17 2004 215 220
40. B.D. Kahan Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomized multicentre study. The Rapamune U.S. Study Group Lancet 356 2000 194 202
41. A.S. MacDonald A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts Transplantation 71 2001 271 280
42. C.G. Groth, L. Backman, J.M. Morales Sirolimus based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group Transplantation 67 1999 1036 1042
43. H. Kreis, J.M. Cisterne, W. Land Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients Transplantation 74:v69 2000 1252 1260
44. M. Cole, N. Maham, C. Cardella Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients Transplantation 75 2003 2086 2090
45. R.A. Sells, A. Bakran, M.W. Brown A prospective randomized study of CSA monotherapy versus CSA + mycophenolate mofetil in cadaveric renal recipients, in Program and Abstracts of the 3rd International Conference on New Trends in Clinical and Experimental Immunosuppression 1998 Geneva, Switzerland, February 12-15
46. M. Weir, L. Anderson, J. Fink A novel approach to the treatment of chronic allograft nephropathy Transplantation 64 1997 1706 1710
47. V. Sanchez, J. Delgado, R. Morales Chronic cyclosporine-induced nephrotoxicity in heart transplant patients Long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine Transplantation Proc 36 2004 2823 2825
48. M. Weir, S. Blahut, C. Drachenburg Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function Am J Nephrol 24 2004 379 386
49. C. Dudley, E. Pohanka, H. Riad Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction The "Creeping Creatinine" Study Transplantation 79 2005 466 475
50. RAPAMUNE (sirolimus) 3-year safety update, Protocol No. 0468H1-310-GL. Madison, NJ, Wyeth Pharmaceuticals
51. J.M. Grinyo, S. Gil-vernet, J.M. Cruzad Calcineurin inhibitor free immunosuppression based on antithymocyte globulin and mycophenolate mofetilin cadaveric kidney transplantation Transplant Int 16 2003 820 827